Stay updated with breaking news from Package Leaflet. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Phase 1/2 clinical trial of COVID-19-Influenza combination vaccine candidate indicates vaccine is well-tolerated and immunogenicData from this combination trial will inform planned Phase 2 dose
/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious...
/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious...
Nuvaxovid is the first protein-based COVID-19 vaccine approved for use in adults aged 18 and older in JapanApproval is first in the world for NVX-CoV2373 that includes both primary and booster
/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious...